InMed Pharmaceuticals Inc.INMNASDAQ
Loading
Interest Expense Over TimeContracting
Percentile Rank87
5Y CAGR-43.9%
Studio
Year-over-Year Change

Interest expense on outstanding debt

5Y CAGR
-43.9%/yr
Long-term compound
Percentile
P87
Within normal range
vs 5Y Ago
0.1x
Contraction
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$20000.00-94.6%
2025$373105.00-
2024$0.00-
2023$0.00-
2022$0.00-100.0%
2021$360350.00+1835.7%
2020$18616.00-
2019$0.00-
2018$0.00-100.0%
2017$495.17-